|This article needs to be updated. (April 2016)|
|Marc Coucke (Founder)|
|Products||Prescription-free medicines and healthcare products|
|Revenue||€1.27 billion (2014)|
|€200 million (2014)|
|Profit||€69.5 million (2010)|
|Total assets||€1.443 billion (end 2010)|
|Total equity||€718.3 million (end 2010)|
Number of employees
|2,130 (end 2010)|
|Parent||Perrigo Company plc|
Founded in 1987 by Marc Coucke and Yvan Vindevogel, both former pharmacy students at the Ghent University, Omega Pharma was initially listed as a Naamloze vennootschap on the Euronext Brussels and used to be part of the BEL20 index until late 2011 when Coucke and private equity firm Waterland took the company private. Omega Pharma was officially acquired by Perrigo with effect from 31 March 2015.
At the annual shareholders meeting of Omega Pharma held on 6 June 2006, it was announced that the company's professional health division would operate under the name of Arseus. Simultaneously, the management team of Arseus was presented. The legal structure of the entities in this division has been largely prepared in the mean time, so that the project to make Arseus an autonomous company is on schedule. Arseus became effectively an independent entity via an IPO on 5 October 2007 and has been listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam since then.
- "Perrigo Company plc Completes Acquisition Of Omega Pharma Invest N.V., Creating A Top Five Global OTC Company". PR Newswire Association LLC. PR Newswire. 30 March 2015. Retrieved 1 July 2015.
- "Annual Report 2010" (PDF). Omega Pharma. Retrieved 22 April 2011.
- "Perrigo to buy Belgium's Omega Pharma for $3.11 billion". Thomson Reuters. Reuters. 6 November 2014.
|This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.|